Skip to content

ZYME - Zymeworks Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchZ

Zymeworks Inc. Common Stock

ZYME · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

Z

ZYMEZymeworks Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $29.75
52-wk low: $13.60
Prev close: $21.48
Mkt cap: $1.93B
Fwd P/E: 84.0x
Beta: 1.15

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$220.8M

CI
Citadel
Ken Griffin · Q2 2026 13F
$23.9M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 10.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 84.03
Market cap: $1.9B

Valuation

P/S52.01
P/B23.02

Quality

Operating margin-919.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ZYME
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.93B
Beta: 1.15

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

52.0x

P/B

23.0x

Profit margin

+0.0%

Op margin

-919.0%

ROE

-72.3%

$15.5M

position

MI

Millennium

Israel Englander · Q4 2025 13F

$10.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ZYME

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.62-10.7%

-$0.56 expected

Next report

What the street expects next

ROE

-72.3%

ROA-24.1%

Growth

Beta1.15